Sign In
Get Clay Free →

Suggestions

    Maryna Kolochavina

    Rare and Orphan│Ultra-rare│Pediatrics│Advanced Therapy│Combined Medicinal Products│Omics│ Asset Integrated Lifecycle Management│Asset & Franchise Strategy│Asset & Portfolio Transactions│Patient’s Ecosystem

    Maryna Kolochavina is an experienced executive leader in the pharmaceutical industry, specializing in rare and orphan medicinal products. She holds a PharmD and PhD, and is certified as a Project Management Professional (PMP).2

    As of February 2025, Maryna has over 18 years of experience in lifecycle asset management for rare and orphan drugs.2 Her expertise spans across:

    1. Managing over 242 rare and orphan medicinal products and advanced therapies
    2. Working with 42 therapeutic classes
    3. Handling 440 orphan drug designations
    4. Contributing to approximately $3.2 billion in capital committed to alliances with biotechnology and pharmaceutical partners2

    At Syneos Health, Maryna serves as the Executive Director of Integrated Lifecycle Management for Rare Diseases.13 Her role involves:

    • Planning and executing multiple study phases (pre-clinical to phase IV)
    • Managing various study designs, including registries, compassionate use programs, and safety surveillance studies
    • Overseeing rare Advanced Therapy Medicinal Product (ATMP) and stem cell studies, as well as Omics studies3

    Maryna is also an active patient advocate, representing the Patient Voice initiative at Charité in Berlin, Germany.23 She is a member of 14 organizations and sits on one board of directors.2

    Her educational background includes a PharmD in clinical pharmacology from Gdansk Medical Academy and translational work in rare skin diseases.3 Maryna holds multiple certifications, including ACRP, BARQA, ASQ, and PMI.3

    Highlights

    Sep 4 · syneoshealth.com
    An Integrated Development Plan in Rare & Orphan Medicinal Products
    Sep 24 · xtalks.com
    Real-World Data Collection in Early Access Programs - Xtalks
    Real-World Data Collection in Early Access Programs - Xtalks
    INC Research and inVentiv Health complete merger

    Related Questions

    What are some of the key projects Maryna Kolochavina has led at Syneos Health?
    How has Maryna Kolochavina's work impacted the treatment of rare diseases?
    What are Maryna Kolochavina's main responsibilities as Executive Director at Syneos Health?
    Can you provide examples of Maryna Kolochavina's achievements in lifecycle management?
    How does Maryna Kolochavina's background in biotechnology and clinical pharmacology influence her work?
    Maryna Kolochavina
    Maryna Kolochavina, photo 1
    Maryna Kolochavina, photo 2
    Add to my network

    Location

    Berlin Metropolitan Area